A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)

NCT04852705 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

28000

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: SARS-CoV-2 Vaccine (Vero Cells), Inactivated
BIOLOGICAL: Placebo

Sponsor

Shenzhen Kangtai Biological Products Co., LTD

Collaborators

[object Object]